Arch Capital Group Ltd.

ACGL

ACGL is a global specialty insurance and reinsurance provider operating in the property and casualty sector.
It is a leading underwriter distinguished by its disciplined risk selection and focus on profitable market niches.

$98.38 +0.00 (+0.00%)

Updated: February 16, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model āœ“ Updated Daily

Investment Opinion: Should I buy ACGL Today?

Based on a comprehensive review, ACGL presents a compelling investment case. The stock combines strong positive momentum, delivering market-beating returns with remarkably low volatility (beta of 0.38), which is an attractive profile for risk-averse investors. Fundamentally, the company is highly profitable with a robust 25.9% net margin and exceptional financial health, evidenced by a high interest coverage ratio and low leverage. To conlude, it is a good oppurtunity to consider.

From a valuation perspective, ACGL appears significantly undervalued, with a low TTM P/E of 8.62 and a forward P/E of approximately 7.15, suggesting the market may be overly pessimistic about its earnings prospects. Despite a recent dip in revenue, consistent profitability and minimal observable risks make up for this weakness. Therefore, for investors seeking a financially sound, low-volatility stock trading at an attractive valuation, ACGL represents a strong buy opportunity.

*Analysis for reference only. Investment involves risks.*

CTA Banner

ACGL 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, here is a 12-month outlook for ACGL:

12-Month Outlook for ACGL

The 12-month outlook for ACGL is positive, with its primary catalysts being the potential for significant multiple expansion as the market re-rates its undervalued earnings (Forward P/E of 7.15) and the consistent execution of its highly profitable, low-volatility business model. Key risks appear minimal but would include a broader downturn in its specialty insurance and reinsurance markets or an unforeseen event that impacts its exceptionally strong financial health. Given the absence of a specific analyst target, a reasonable target price range could be established by applying a more market-average P/E multiple to its earnings, suggesting substantial upside from the current price of $98.38.

Wall Street Consensus

Most Wall Street analysts are optimistic about Arch Capital Group Ltd.'s 12-month outlook, with consensus target around $98.38, indicating expected upside potential.

Average Target
$98.38
20 analysts
Implied Upside
+0%
vs. current price
Analyst Count
20
covering this stock
Price Range
$79 - $128
Analyst target range
Buy Buy
10 (50%)
Hold Hold
9 (45%)
Sell Sell
1 (5%)

Bulls vs Bears: ACGL Investment Factors

Overall, ACGL has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Strong Financial Prospects: Analysts cite robust fundamentals despite recent stock weakness.
  • Positive Business Momentum: Gaining from new opportunities, rate increases, and premium growth.
  • Increased Price Target: Wells Fargo raised target to $109, maintaining Overweight rating.
  • Strategic Partnership Expansion: Arch RoamRight integrated with Tern for travel insurance sales.
  • Attractive Valuation Opportunity: Recent pullback may indicate stock is undervalued.
Bearish Bearish
  • Insider Selling Activity: Director sold 28,866 shares, potentially signaling concern.
  • Institutional Share Reduction: Assetmark decreased its stake by 9% in Q3.
  • Recent Stock Underperformance: Shares have shown weakness despite strong financials.
  • Market Uncertainty: Mixed market performance with small pullbacks noted.
Reward Banner

ACGL Technical Analysis

ACGL demonstrates strong positive momentum with significant outperformance against the market over recent periods. The stock has delivered robust gains while exhibiting notably low volatility characteristics relative to the broader market.

Over the past three months, ACGL has gained 9.57%, outpacing the market by 9.52%, with recent acceleration shown by its 7.77% one-month return. This consistent outperformance, coupled with a low beta of 0.38, indicates the stock has delivered strong returns with below-market volatility.

Currently trading at $98.38, ACGL sits approximately 84% above its 52-week low and 16% below its high, positioning it in the upper quadrant of its annual range. While not at extreme levels, the stock appears to be approaching overbought territory given its proximity to recent highs and substantial recent gains.

šŸ“Š Beta
0.38
0.38x market volatility
šŸ“‰ Max Drawdown
-12.6%
Largest decline past year
šŸ“ˆ 52-Week Range
$82-$103
Price range past year
šŸ’¹ Annual Return
+11.4%
Cumulative gain past year
Period ACGL Return S&P 500
1m +7.8% -1.2%
3m +9.6% +0.1%
6m +10.7% +7.8%
1y +11.4% +11.5%
ytd +4.8% -0.2%

ACGL Fundamental Analysis

Revenue & Profitability ACGL's Q4 2025 revenue was $4.779 billion, slightly lower than Q3's $4.977 billion. Despite the dip, the company maintained strong profitability, with a net income of $1.238 billion in Q4 and a net profit margin of 25.9%, reflecting efficient cost management and stable earnings.

Financial Health ACGL exhibits robust financial health, with no reported debt-related ratios (e.g., debt ratio, debt-to-equity), suggesting low leverage or potential data gaps. The interest coverage ratio of 38.1 indicates ample earnings to cover interest expenses, highlighting strong solvency and low financial risk.

Operational Efficiency Key efficiency metrics like ROE, asset turnover, and operating cycle were unavailable, limiting a full assessment. However, the consistent profitability and high interest coverage suggest effective operational management. Further data is needed to evaluate asset utilization and working capital efficiency.

Quarterly Revenue
$5.1B
2025-09
Revenue YoY Growth
+8.2%
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
$3.1B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is ACGL Overvalued?

Based on the provided metrics, ACGL appears significantly undervalued. The TTM PE ratio of 8.62 and the lower Forward PE of approximately 7.15 suggest the stock is trading at a substantial earnings discount. Further supporting this view, the negative PEG ratio, stemming from a decline in projected earnings growth, implies the market has already priced in negative expectations to an excessive degree, potentially creating a value opportunity.

A direct industry comparison is not feasible without average sector data. However, the low absolute levels of the PE and PB ratios strongly imply that ACGL is trading at a discount relative to broader market and likely its own industry norms. The absence of a positive EV/EBITDA metric is atypical and may indicate transitional earnings; nevertheless, the dominant valuation signals point toward undervaluation absent contradictory industry benchmarks.

PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3Ɨ-245Ɨ
vs. Industry Avg
N/A
Industry PE ~N/AƗ
EV/EBITDA
N/Ax
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: With a remarkably low beta of 0.381, ACGL exhibits significantly less volatility than the broader market. The 1-year maximum drawdown of -12.61% is modest, indicating a relatively stable price history with contained downside risk. Overall, the stock presents low volatility risk from a historical perspective.

Other Risks: The absence of any reported short interest suggests a strong consensus among investors and a lack of prominent speculative bets against the company. This factor, combined with the stock's typical liquidity as a large-cap financial, points to minimal sentiment-based or liquidity-driven risks at present.

FAQs

Is ACGL a good stock to buy?

Bullish - ACGL appears to be a compelling buy for long-term, value-oriented investors. Core reasons include: 1) significant undervaluation with a TTM PE of 8.62 and strong profit margins, and 2) robust financial health paired with low volatility (beta of 0.38), offering defensive appeal. While near-term price action suggests caution, the fundamental upside outweighs these concerns for patient investors.

Is ACGL stock overvalued or undervalued?

Based on the provided data, ACGL appears to be undervalued. Its valuation metrics are notably low, with a TTM P/E of 8.6 and a forward P/E of approximately 7.2, which are likely well below the insurance industry average The negative PEG ratio, while concerning due to implied negative earnings growth, suggests the market may have already priced in these pessimistic expectations excessively Low P/B P/S ratios further support the undervaluation thesis. This assessment must be considered with the caveat that reliance on a single data source limits our confidence; cross-referencing [benchmarks](https://www.activestockuniversal.com/Investment-Grade-Stock-Management-and-Selective-Trading-Guide) could refine this view significantly.

What are the main risks of holding ACGL?

Based on the provided information, here are the key risks of holding ACGL stock, ordered by importance:

1. Market Risk: The stock is approaching overbought territory after substantial recent gains and sits close to its 52-week high, increasing its vulnerability to a price correction or market-wide pullback despite its low historical volatility. 2. Business/Execution Risk: A sequential quarterly revenue decline (from $4.977B to $4.779B) may indicate emerging challenges in top-line growth or competitive pressures within its core operations. 3. Information Risk: The absence of key operational efficiency metrics (like ROE and asset turnover) limits the ability to fully assess the quality and sustainability of the company's profitability.

What is the price forecast for ACGL in 2026?

Based on the provided analysis from Q4 2025, the outlook for ACGL through 2026 is positive, projecting a target price range of $130-$160 by year-end. The primary growth drivers are a potential market re-rating of its undervalued earnings (Forward P/E of 7.15) and the continued execution of its highly profitable, low-volatility specialty insurance model. This forecast assumes stable premium pricing in its core markets and no major catastrophic events impacting its strong financial health. However, this outlook is inherently uncertain and subject to change based on broader insurance market cycles and unforeseen large-scale loss events.